MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $65.96MP/E –Yield –
MediciNova cash
Cash and short-term investments held at the end of each period.
MediciNova's cash was $25.42M at Jun 30, 2026. For fiscal 2025 it was $30.81M, down 23.7% from the year before. Over ten years it grew 3.4% a year on average. The highest annual figure on record is $71.43M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.81M | -23.7% |
| FY2024 | Dec 31, 2024 | $40.36M | -20.9% |
| FY2023 | Dec 31, 2023 | $51.00M | -12.8% |
| FY2022 | Dec 31, 2022 | $58.49M | -18.1% |
| FY2021 | Dec 31, 2021 | $71.43M | +19.0% |
| FY2020 | Dec 31, 2020 | $60.04M | -5.9% |
| FY2019 | Dec 31, 2019 | $63.79M | +2.4% |
| FY2018 | Dec 31, 2018 | $62.31M | +122.6% |
| FY2017 | Dec 31, 2017 | $27.99M | +16.1% |
| FY2016 | Dec 31, 2016 | $24.12M | +9.2% |
| FY2015 | Dec 31, 2015 | $22.08M | +89.2% |
| FY2014 | Dec 31, 2014 | $11.67M | +74.2% |
| FY2013 | Dec 31, 2013 | $6.70M | +67.1% |
| FY2012 | Dec 31, 2012 | $4.01M | -73.4% |
| FY2011 | Dec 31, 2011 | $15.09M | -46.6% |
| FY2010 | Dec 31, 2010 | $28.25M | +46.8% |
| FY2009 | Dec 31, 2009 | $19.24M | -0.3% |
| FY2008 | Dec 31, 2008 | $19.30M | – |
| FY2000 | Dec 31, 2000 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $25.42M | -25.8% |
| Q1 FY2026 | Mar 31, 2026 | $27.33M | -25.3% |
| Q4 FY2025 | Dec 31, 2025 | $30.81M | -23.7% |
| Q3 FY2025 | Sep 30, 2025 | $32.56M | -23.0% |
| Q2 FY2025 | Jun 30, 2025 | $34.26M | -22.7% |
| Q1 FY2025 | Mar 31, 2025 | $36.57M | -22.4% |
| Q4 FY2024 | Dec 31, 2024 | $40.36M | -20.9% |
| Q3 FY2024 | Sep 30, 2024 | $42.28M | -17.9% |
| Q2 FY2024 | Jun 30, 2024 | $44.34M | -16.1% |
| Q1 FY2024 | Mar 31, 2024 | $47.14M | -14.7% |
| Q4 FY2023 | Dec 31, 2023 | $51.00M | -12.8% |
| Q3 FY2023 | Sep 30, 2023 | $51.51M | -1.9% |
| Q2 FY2023 | Jun 30, 2023 | $52.88M | -18.9% |
| Q1 FY2023 | Mar 31, 2023 | $55.26M | -18.4% |
| Q4 FY2022 | Dec 31, 2022 | $58.49M | -18.1% |
| Q3 FY2022 | Sep 30, 2022 | $52.51M | -30.0% |
| Q2 FY2022 | Jun 30, 2022 | $65.23M | -16.1% |
| Q1 FY2022 | Mar 31, 2022 | $67.70M | -11.3% |
| Q4 FY2021 | Dec 31, 2021 | $71.43M | +19.0% |
| Q3 FY2021 | Sep 30, 2021 | $75.03M | +21.7% |
| Q2 FY2021 | Jun 30, 2021 | $77.79M | +28.7% |
| Q1 FY2021 | Mar 31, 2021 | $76.30M | +24.4% |
| Q4 FY2020 | Dec 31, 2020 | $60.04M | -5.9% |
| Q3 FY2020 | Sep 30, 2020 | $61.66M | -1.9% |
| Q2 FY2020 | Jun 30, 2020 | $60.44M | -2.1% |
| Q1 FY2020 | Mar 31, 2020 | $61.33M | -3.0% |
| Q4 FY2019 | Dec 31, 2019 | $63.79M | +2.4% |
| Q3 FY2019 | Sep 30, 2019 | $62.87M | +0.7% |
| Q2 FY2019 | Jun 30, 2019 | $61.74M | -3.8% |
| Q1 FY2019 | Mar 31, 2019 | $63.21M | +0.4% |
| Q4 FY2018 | Dec 31, 2018 | $62.31M | +122.6% |
| Q3 FY2018 | Sep 30, 2018 | $62.44M | +154.5% |
| Q2 FY2018 | Jun 30, 2018 | $64.16M | +180.3% |
| Q1 FY2018 | Mar 31, 2018 | $62.94M | +190.9% |
| Q4 FY2017 | Dec 31, 2017 | $27.99M | +16.1% |
| Q3 FY2017 | Sep 30, 2017 | $24.54M | -1.7% |
| Q2 FY2017 | Jun 30, 2017 | $22.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $21.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.12M | – |
| Q3 FY2016 | Sep 30, 2016 | $24.97M | – |
See a number that looks wrong?